An Open Label, Single Arm Clinical Study of Intravitreal Injection of Conbercept in Patients With Maculae Edema Secondary to Retinal Vein Occlusion (the FALCON Study)
Phase of Trial: Phase II
Latest Information Update: 31 Jan 2019
Price : $35 *
At a glance
- Drugs Conbercept (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use
- Acronyms FALCON
- Sponsors Chengdu Kanghong Biotech
- 22 Jan 2018 Sponsor association:However, the company tool also have added Chengdu Kanghong Biotech as a subsidiary of Chengdu Kanghong Pharmaceuticals. I have tagged Chengdu Kanghong Biotech as the sponsor to represent the details similar to CT.gov record.
- 01 Sep 2017 Status changed to completed, according to results published in the Retina Journal.
- 01 Sep 2014 New trial record